News
Becton, Dickinson and Company has struggled over the past decade, with a 10-year CAGR of only 5.1%. Read what keeps me on the ...
The Board of Directors of BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced it has declared a quarterly dividend of $1.04 per common share, ...
Zacks Investment Research on MSN1d
Can Sustained Product Demand Drive BDX Stock Before Q2 Earnings?Becton Dickinson and Company BDX, popularly known as BD, is scheduled to report second-quarter fiscal 2025 results on May 1, ...
Zacks Investment Research on MSN7d
BD Stock Down Despite Monitoring Platform Launch to Boost Patient CareBecton, Dickinson and Company BDX, popularly known as BD, launched a new advanced hemodynamic monitoring platform, HemoSphere ...
GlobalData on MSN5d
BD’s umbilical hernia patch secures FDA 510(k) clearanceBecton, Dickinson and Company (BD) has received the US Food and Drug Administration’s (FDA) 510(k) clearance for the Phasix ...
Former Edwards Lifesciences Critical Care Unit, renamed BD Advanced Patient Monitoring, yesterday launched the HemoSphere ...
Shares of Becton Dickinson & Co. BDX rose 1.22% to $202.32 Wednesday, on what proved to be an all-around favorable trading ...
Becton, Dickinson is the world's largest manufacturer ... as well as flow cytometry and cell-imaging systems. BD Medical is nearly half of the total business, while BD Life Sciences (27% of ...
The Franklin Lakes, New Jersey-based company operates through BD Medical, BD Life Sciences ... For fiscal 2025, analysts expect Becton, Dickinson and Company to report an adjusted EPS of ...
BD introduces next generation hemodynamic monitoring solution providing clinicians with AI-driven clinical decision support: ...
Piper Sandler analyst Jason Bednar lowered the firm’s price target on Becton Dickinson to $260 from $280 and keeps an Overweight rating on the ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback